The FDA panel recommended yesterday that Roche change the warning label for Tamiflu, which has been used by 48 million patients since its launch in 1999.
The drug's label already mentions reports of delirium and self-injury, primarily among children in Japan, but some of the FDA's experts suggested the language should mention that several patients have died as a result of these abnormal behaviors.
Read the entire article.
No comments:
Post a Comment